CXCR2-IN-68;Urea, N-[4-chloro-2-hydroxy-3-[[(3S)-tetrahydro-3-methyl-3-furanyl]sulfonyl]phenyl]-N'-[(1R)-2-methyl-2-cyclopenten-1-yl]-;CXCR2-IN-2;CXCR2IN2,CXCR2 IN 2,CXCR-2-IN-2
CXCR2-IN-2 is a selective, brain-penetrant, orally bioavailable CXCR2 antagonist used for inhibiting Gro-α-induced CD11b expression in human whole blood; it exhibits high selectivity over CXCR1 (~730-fold) and other chemokine receptors (>1900-fold), making it suitable for research and potential therapeutic applications targeting CXCR2-mediated inflammatory and neurological disorders.